Navidea: Navidea drops only active drug candidate after failure of key test
After suspending all activities in a clinical trial, Navidea Biopharmaceuticals Inc. set the stage on Monday for cutting out thousands of retail shareholders.
Read full article »
CEO
- -Navidea is an Ohio-based biopharmaceutical company that researches and develops immunotherapeutics for the treatment of cancer, autoimmune, infectious, and inflammatory diseases.
Read more